IL128517A - Dihydropyrones with improved antiviral activity - Google Patents

Dihydropyrones with improved antiviral activity

Info

Publication number
IL128517A
IL128517A IL12851797A IL12851797A IL128517A IL 128517 A IL128517 A IL 128517A IL 12851797 A IL12851797 A IL 12851797A IL 12851797 A IL12851797 A IL 12851797A IL 128517 A IL128517 A IL 128517A
Authority
IL
Israel
Prior art keywords
dihydropyrones
antiviral activity
improved antiviral
improved
activity
Prior art date
Application number
IL12851797A
Other languages
English (en)
Other versions
IL128517A0 (en
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL128517A0 publication Critical patent/IL128517A0/xx
Publication of IL128517A publication Critical patent/IL128517A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205Radicals derived from carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/04Thiosulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12851797A 1996-11-01 1997-10-31 Dihydropyrones with improved antiviral activity IL128517A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2990696P 1996-11-01 1996-11-01
US08/883,743 US5834506A (en) 1996-11-01 1997-06-27 Dihydropyrones with improved antiviral activity
PCT/US1997/019853 WO1998019997A2 (en) 1996-11-01 1997-10-31 Dihydropyrones with improved antiviral activity

Publications (2)

Publication Number Publication Date
IL128517A0 IL128517A0 (en) 2000-01-31
IL128517A true IL128517A (en) 2003-07-31

Family

ID=26705464

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12851797A IL128517A (en) 1996-11-01 1997-10-31 Dihydropyrones with improved antiviral activity

Country Status (18)

Country Link
US (2) US5834506A (es)
EP (1) EP0935597A2 (es)
JP (1) JP2001504102A (es)
KR (4) KR100496365B1 (es)
AU (1) AU733700B2 (es)
BR (1) BR9714588A (es)
CA (1) CA2263429A1 (es)
CO (1) CO4910146A1 (es)
HR (1) HRP970571A2 (es)
IL (1) IL128517A (es)
MX (1) MXPA99001777A (es)
MY (1) MY118131A (es)
NO (1) NO992103D0 (es)
NZ (2) NZ507184A (es)
PE (1) PE13799A1 (es)
PL (1) PL332904A1 (es)
TW (1) TW536536B (es)
WO (1) WO1998019997A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014210A1 (en) * 1997-09-15 1999-03-25 Warner-Lambert Company Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
US6380400B1 (en) 1998-09-11 2002-04-30 Victor Fedij Methods of making dihydropyrone HIV protease inhibitors
WO2000015634A2 (en) * 1998-09-11 2000-03-23 Warner-Lambert Company Hiv protease inhibitors
US6054623A (en) * 1998-12-18 2000-04-25 Alliedsignal Inc. Hydroxythiol grignard reaction synthesis
US6512006B1 (en) * 1999-12-09 2003-01-28 Warner-Lambert Company HIV protease inhibitors
AU2001289831A1 (en) * 2000-09-06 2002-03-22 Bayer Aktiengesellschaft Medicaments against viral infections
DE10108471C1 (de) 2001-02-22 2002-11-21 Boehringer Ingelheim Pharma Kontinuierliches Verfahren zur Herstellung von 5,6-Dihydro-4-hydroxy-2-pyronen
US7141681B2 (en) 2001-02-22 2006-11-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Continuous process for preparing dihydropyrones
EP1377549A1 (en) * 2001-03-12 2004-01-07 Millennium Pharmaceuticals, Inc. Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
DE10257761A1 (de) 2002-12-10 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung optisch aktiver Dihydropyrone
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
AP2313A (en) * 2004-08-18 2011-10-31 Pfizer Inhibitors of hepatitis C virus RNA-dependent RNA ploymerase, and compositions and treatments using the same.
UA119963C2 (uk) 2007-12-20 2019-09-10 Фарма Мар, С.А. Протипухлинні сполуки
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57167296A (en) * 1981-04-09 1982-10-15 Ricoh Co Ltd Heat-sensitive recording material
JP3698435B2 (ja) * 1993-11-19 2005-09-21 パーク・デイビス・アンド・カンパニー プロテアーゼ阻害剤および抗ウイルス剤としての5,6−ジヒドロピロン誘導体
JP3684426B2 (ja) * 1993-11-19 2005-08-17 パーク・デイビス・アンド・カンパニー プロテアーゼ阻害剤および抗ウイルス剤としての5,6−ジヒドロピロン誘導体
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

Also Published As

Publication number Publication date
WO1998019997A2 (en) 1998-05-14
NZ334701A (en) 2001-01-26
NO992103L (no) 1999-04-30
US5834506A (en) 1998-11-10
KR100496365B1 (ko) 2005-06-21
KR20000052951A (ko) 2000-08-25
MY118131A (en) 2004-09-30
PL332904A1 (en) 1999-10-25
KR20040104644A (ko) 2004-12-10
CA2263429A1 (en) 1998-05-14
MXPA99001777A (es) 2003-08-10
AU5100198A (en) 1998-05-29
JP2001504102A (ja) 2001-03-27
WO1998019997A3 (en) 1998-08-27
IL128517A0 (en) 2000-01-31
NO992103D0 (no) 1999-04-30
BR9714588A (pt) 2000-05-30
KR100496366B1 (ko) 2005-06-21
HRP970571A2 (en) 1998-08-31
KR20040104646A (ko) 2004-12-10
US6046355A (en) 2000-04-04
KR100496367B1 (ko) 2005-06-22
NZ507184A (en) 2002-02-01
KR20040104645A (ko) 2004-12-10
EP0935597A2 (en) 1999-08-18
CO4910146A1 (es) 2000-04-24
PE13799A1 (es) 1999-02-26
AU733700B2 (en) 2001-05-24
TW536536B (en) 2003-06-11

Similar Documents

Publication Publication Date Title
TW373796U (en) Keystoke structure
IL128517A (en) Dihydropyrones with improved antiviral activity
GB9710773D0 (en) Cytofunnel arrangement
GB9706400D0 (en) Distributed computing
GB9715267D0 (en) Stethescope structure
AU8016398A (en) Peptides with antiviral activity
IL118927A0 (en) Battery structure
GR3036656T3 (en) 10-Aminoaliphatyl-dibenz(b,f)oxepins with antineurodegenarative activity
EP1033372A4 (en) COMPOSITIONS WITH ANTI-TUMOR ACTIVITY
GB9707849D0 (en) Structure
ZA975565B (en) Antiviral combinations
AU2991295A (en) Sustance with antiviral activity
GR3036217T3 (en) Arylheterocycles with herbicidal activity
GB2315286B (en) Structure
GB9909038D0 (en) Spar structure
ZA979777B (en) Dihydropyrones with improved antiviral activity.
GB9625941D0 (en) Anthraquinones with biological activity
GB2329063B (en) Activity toy
ZA975564B (en) Antiviral combinations
GB9719866D0 (en) Antiviral Combinations
GB9719883D0 (en) Antiviral combinations
GB9609665D0 (en) Triterpine derivatives with immunosuppressant activity
ZA965718B (en) New pyrido-thiopyranoindazoles with anti-tumor activity
GB9614024D0 (en) Antiviral therapeutic combinations
GB9614022D0 (en) Antiviral therapeutic combinations

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees